| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 08/22/2002 | DE10108271A1 Chinolin-, Isochinolin- und Phthalazinderivate als Antagonisten des Gonadotropin freisetzenden Hormons Quinoline, isoquinoline and phthalazine derivatives releasing as antagonists of gonadotropin hormone |
| 08/22/2002 | CA2856986A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | CA2666611A1 Novel succinate salt of o-desmethyl-venlafaxine |
| 08/22/2002 | CA2438641A1 Stabilized pharmaceutical and thyroid hormone compositions and method of preparation |
| 08/22/2002 | CA2438215A1 Putative human enzymes |
| 08/22/2002 | CA2438153A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | CA2437118A1 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/22/2002 | CA2433843A1 Molecules for disease detection and treatment |
| 08/21/2002 | EP1232756A1 Drugs, drinks or foods |
| 08/21/2002 | EP1232748A1 Substituted nitrobenzene derivatives as medicines and other useful uses thereof |
| 08/21/2002 | EP1232259A1 Human galanin family proteins and polynucleotides encoding the same |
| 08/21/2002 | EP1232247A2 Modulation of signal transduction |
| 08/21/2002 | EP1232175A2 Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof |
| 08/21/2002 | EP1231924A2 Treatment of systemic lupus erythematosus (sle) with dehydroepiandrosterone |
| 08/21/2002 | EP1231913A2 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 08/21/2002 | EP0752882B1 Treatment for diabetes |
| 08/21/2002 | CN1089245C Soy extract, process for its prepn. and pharmaceutical compsn. |
| 08/20/2002 | US6437165 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. |
| 08/20/2002 | US6437143 Thiazolidone-2 derivatives, 4-diketone substituted, method for obtaining them and pharmaceutical compositions containing same |
| 08/20/2002 | US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 08/20/2002 | US6436923 Compounds and methods for modulation of estrogen receptors |
| 08/20/2002 | US6436684 Isolated nucleic acid molecule consisting of selected nucleotide sequence encoding phenol sulfotransferase protein |
| 08/20/2002 | US6436642 Method of classifying a thyroid carcinoma using differential gene expression |
| 08/15/2002 | WO2002063006A2 Receptors and membrane-associated proteins |
| 08/15/2002 | WO2002062844A2 Long lasting growth hormone releasing factor derivatives |
| 08/15/2002 | WO2002062804A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 08/15/2002 | WO2002062799A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents |
| 08/15/2002 | WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/15/2002 | WO2002062780A2 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands |
| 08/15/2002 | WO2002062391A2 Method of using a cyclooxygenase-2 inhibitor and sex steroids as a combination therapy for the treatment and prevention of dismenorrhea |
| 08/15/2002 | WO2002022212A8 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 08/15/2002 | WO2002015938A3 Testosterone ester formulation for human use |
| 08/15/2002 | WO2001077177A3 Gpcr-proteins and nucleic acids encoding same |
| 08/15/2002 | WO2001044273A3 Receptor-selective somatostatin analogs |
| 08/15/2002 | US20020111374 Estrogen receptor modulators |
| 08/15/2002 | US20020111355 Antitumor agents; contraceptives |
| 08/15/2002 | US20020111353 Antiinflammatory agents; central nervous system disorders;antidiabgetic agents; rheumatic disorders |
| 08/15/2002 | US20020111306 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 08/15/2002 | US20020110539 Modulated release particles for lung delivery |
| 08/15/2002 | US20020110526 Modulated release particles for lung delivery |
| 08/15/2002 | US20020110524 Method for stabilizing biomolecules in liquid formulations |
| 08/15/2002 | CA2437571A1 Receptors and membrane-associated proteins |
| 08/15/2002 | CA2437260A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 08/15/2002 | CA2436741A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents |
| 08/15/2002 | CA2435820A1 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands |
| 08/15/2002 | CA2435563A1 Long lasting growth hormone releasing factor derivatives |
| 08/15/2002 | CA2435350A1 Method of using a cyclooxygenase-2 inhibitor and sex steroids as a combination therapy for the treatment and prevention of dismenorrhea |
| 08/14/2002 | EP1231212A1 Pharmaceutical compositions for the treatment of disorders of the CNS and other disorders |
| 08/14/2002 | EP1231211A1 Thiazolidinedione derivatives as antidiabetic agents |
| 08/14/2002 | EP1230928A1 Use of peptide |
| 08/14/2002 | EP1230369A2 Polypeptide hormone phosphatonin |
| 08/14/2002 | EP1230367A1 19 human secreted proteins |
| 08/14/2002 | EP1230254A1 Antisense modulation of src-3 expression |
| 08/14/2002 | EP1230236A1 Compound with growth hormone releasing properties |
| 08/14/2002 | EP1230227A1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 08/14/2002 | EP1230214A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 08/14/2002 | EP1229909A2 Transdermal delivery of lasofoxifene |
| 08/14/2002 | EP1229903A1 A method for chemoprevention of prostate cancer |
| 08/14/2002 | CN1364155A N-Cyanomethyl amides as protease inhibitors |
| 08/14/2002 | CN1364093A Improvement of T cell mediated immunity |
| 08/14/2002 | CN1364077A Multilayer pharmaceutical product for release in the colon |
| 08/13/2002 | US6433171 Dipeptide derivatives |
| 08/13/2002 | US6433000 Aromatic sulfamate derivatives as sulfatase inhibitors; estrogen receptor blockers; breast cancer treatment |
| 08/13/2002 | US6432994 Cardiovascular disorders, glaucoma; antiinflammatory, wound healing, hypotensive, antiasthmatic, and antianaphylactic agents |
| 08/13/2002 | US6432993 Substituted fused heterocyclic compound |
| 08/13/2002 | US6432989 Use of CRF antagonists to treat circadian rhythm disorders |
| 08/13/2002 | US6432982 Benzothiophenes, and formulations and methods using same |
| 08/13/2002 | US6432945 Dipeptide derivatives |
| 08/13/2002 | US6432940 Uses for androst-5-ene-3β, 17β-diol |
| 08/12/2002 | CA2369967A1 Methods of treating nuclear factor-kappa b mediated diseases and disorders |
| 08/08/2002 | WO2002060899A1 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them |
| 08/08/2002 | WO2002060878A1 Benzimidazolidinone derivatives |
| 08/08/2002 | WO2002060411A2 Process for production of nanoparticles and microparticles by spray freezing into liquid |
| 08/08/2002 | WO2002060388A2 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| 08/08/2002 | WO2002044142A3 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders |
| 08/08/2002 | WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | WO2002028165A3 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 08/08/2002 | WO2002019971A9 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 08/08/2002 | WO2002014347A3 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts |
| 08/08/2002 | WO2002010140A3 Imidazolyl derivatives |
| 08/08/2002 | WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 08/08/2002 | WO2001096546A3 Protein phosphatases |
| 08/08/2002 | WO2001093840A3 Ligands of integrin receptors |
| 08/08/2002 | WO2001085784A9 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF |
| 08/08/2002 | WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec) |
| 08/08/2002 | WO2001009090A3 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 08/08/2002 | WO2000074736A9 Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same |
| 08/08/2002 | US20020107406 Calcium receptor-active compounds |
| 08/08/2002 | US20020107363 B7-Like molecules and uses thereof |
| 08/08/2002 | US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | US20020107256 Polymorphs of N-methyl-N-(3-{3-[2- thienylcarbonyl]-pyrazol-[1,5-alpha]- pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto |
| 08/08/2002 | US20020107254 P-substituted-N-(2-(4-(2,3-dihydro-benzo(1,4)dioxin-5-yl) -piperazin-1-yl)-propyl)-N-pyridin-2-yl-benzamide, |
| 08/08/2002 | US20020107235 Carbamate and hydroxy groups containing phenanthrene derivatives; useful to treat obesity, diabetes and inflammation |
| 08/08/2002 | US20020106655 Nucleotide sequences coding preferential protein for use in the treatment, diagnosis and prevention of immunological, nervous system and tumor disorders |
| 08/08/2002 | US20020106650 Nucleotide sequence coding preferential polypeptide; for use in the treatment, prevention and diagnosis of kidney, liver, reproductive and cardiovascular disorders |
| 08/08/2002 | US20020106354 Cellular and animal models for diseases associated with altered mitochondrial function |
| 08/08/2002 | CA2436556A1 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them |
| 08/08/2002 | CA2436418A1 Process for production of nanoparticles and microparticles by spray freezing into liquid |
| 08/08/2002 | CA2434491A1 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| 08/07/2002 | EP1229036A1 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |